Cost-effective universal screening for hepatitis C in France

(ANRS) An estimated 75,000 people in France are unaware they are infected by hepatitis C virus. An ANRS-funded study by Sylvie Deuffic-Burban, a research associate at IAME (Inserm - Université Paris Diderot - Université Paris 13), and her team shows that a universal screening strategy applied to hepatitis C is cost-effective and improves life expectancy in those infected, compared with targeted screening. These modeling results will be published on July 1, 2018, in Journal of Hepatology.